Clinical Trial

The Vancomycin Piperacillin/Tazobactam (VPT) Patient Safety Trial (VPS)

Study acronym: VPS
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The VPT Safety Trial (VPS) compares two common antibiotic combinations to see how they affect the kidneys of patients in the hospital with serious infections. Both combinations are approved by the Food and Drug Administration (FDA). The goal is to help doctors know which combination is safer so they can make better choices for their patients.
Trial Details
NCT Number NCT07556107
Lead Sponsor Bassett Healthcare
Collaborators: Johns Hopkins University, Patient-Centered Outcomes Research Institute
Conditions Infection, Acute Kidney Injury, Sepsis
Enrollment 852 participants
Start Date 2026-06-01
Primary Completion 2028-06-30 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-29